rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17 Mar ' 16
Sources of funds
Owner's fund
Equity share capital 5.00 5.00 5.00 5.00 5.00
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 359.44 295.80 241.93 217.87 151.01
Loan funds
Secured loans - - - - -
Unsecured loans - - - - -
Total 364.44 300.80 246.93 222.87 156.01
Uses of funds
Fixed assets
Gross block 132.84 119.83 105.85 102.57 200.75
Less : revaluation reserve - - - - -
Less : accumulated depreciation 61.31 45.00 30.39 15.73 103.40
Net block 71.53 74.83 75.46 86.84 97.36
Capital work-in-progress 24.24 6.90 3.57 4.81 6.31
Investments - - - - -
Net current assets
Current assets, loans & advances 610.59 480.07 381.51 323.84 302.05
Less : current liabilities & provisions 341.92 261.00 213.61 192.62 249.71
Total net current assets 268.67 219.07 167.90 131.22 52.35
Miscellaneous expenses not written - - - - -
Total 364.44 300.80 246.93 222.87 156.01
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments - - - - 0.01
Contingent liabilities 69.19 32.57 11.85 17.25 42.75
Number of equity sharesoutstanding (Lacs) 250.00 250.00 250.00 250.00 250.00

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close